Clinical Trial Update: SureScan Post-Approval Study

View source ↗

Summary

Medtronic's SureScan post-approval study in bradycardia patients has completed, reporting post-market safety and performance results of the device.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bradycardia

Snippet

Sponsor: Medtronic | Conditions: Bradycardia | Status: COMPLETED